期刊文献+

通痹化纤方对肺纤维化大鼠肺功能及uPA、PAI-1、TNF-α表达的影响 被引量:1

Effect of Tongbi Huaxian Decoction on lung function of rats with pulmonary fibrosis and expression of uPA,PAI-1 and TNF-α
下载PDF
导出
摘要 目的观察通痹化纤方对肺纤维化大鼠肺功能及肿瘤坏死因子-α(TNF-α)、尿激型纤溶酶原激活剂(uPA)和纤溶酶原激活剂抑制剂-1(PAI-1)表达的影响,探讨该方治疗肺纤维化大鼠的作用机制。方法将70只大鼠随机分为空白组、模型组、激素组、中药组,气管内注射博来霉素造成肺纤维化大鼠模型,造模后28天予以相应药物灌胃给药,连续给药21天。检测各组大鼠肺组织病理形态学、肺功能、血清及支气管肺泡灌洗液uPA和PAI-1水平、血清TNF-α水平的变化。结果模型组呈中重度肺纤维化改变,中药和激素组肺泡炎和肺纤维化程度均较模型组明显减轻;与模型组比较,中药和激素组TNF-α水平明显降低(P<0.05);与空白组比较,其余各组大鼠血清uPA水平明显降低(P<0.05);与空白组比较,模型组大鼠MVV水平明显降低(P<0.05);与空白组比较,模型组大鼠Cydn水平明显降低(P<0.05),与模型组比较,中药和激素组Cydn水平明显升高(P<0.05);与空白组比较,模型组大鼠RL水平明显升高(P<0.05),与模型组比较,中药组RL水平明显降低(P<0.05);与空白组比较,模型组大鼠RE水平明显升高(P<0.05)。结论通痹化纤方可能通过降低肺纤维化大鼠血清中TNF-α水平,改善肺纤维化大鼠Cydn及RL,从而延缓肺纤维化的进程。 Objective To investigate the mechanism of the treatment of pulmonary fibrosis in rats through examining the effect of Tongbi Huaxian Decoction on expression of lung function of rats with pulmonary fibrosis and tumor necrosis factor-α (TNF-α) , urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-1 ( PAI-1 ). Methods Seventy rats are randomly divided into the untreated group, the control group, the hormone treatment group, and the Chinese herbs treatment group. We make the pulmonary fibrosis rat model by intratracheal injection of bleomycin. We start the treatment by giving the appropriate drugs on gavage for 21 continuous days 28 days after the start of the model. We examine lung tissue pathology, changes in lung function, serum and bronchoalveolar lavage fluid of uPA and PAI-1 levels, and serum levels of TNF-α level for each group. Results The control group has severe pulmonary fibrosis while the Chinese herbs and hormone groups have significantly less severe alveolitis and pulmonary fibrosis. Compared to the control group, both treatment groups have significantly lower TNF-α level ( P〈0. 05 ). Compared with the untreated group, all other groups have significantly lower serum uPA level (P〈 0.05 ). Compared with the untreated group, the control group has significantly lower MVV level (P〈0.05). Compared with the untreated group, the control group has significantly lower Cydn level (P〈0. 05) while both treatment groups have significantly higher Cydn level (P〈0.05). Compared with untreated group, the control group has significantly higher RL level ( P〈0.05 ) while the Chinese medicine treatment group has significantly lower RL level ( P〈0.05 ). Compared with the untreated group, the control group has significantly higher RE level ( P〈0.05 ). Conclusion Tongbi Huaxian Decoction may improve Cydn and RL in rats with pulmonary fibrosis through reducing serum TNF-α levels, thereby delaying the process of pulmonary fibrosis.
出处 《环球中医药》 CAS 2012年第9期654-659,共6页 Global Traditional Chinese Medicine
基金 国家自然科学基金(30901948) 中国中医科学院西苑医院院内课题(xyky-mp-05)
关键词 通痹化纤方 肺纤维化 肺功能 UPA PAI-1 TNF-α Tongbi Huaxian Decoction Pulmonary fibrosis Pulmonary function uPA PAI-1 TNF-(P〈0. 05) while both treatment groups have significantly higher Cydn level (P〈0.05). Compared with untreated group, the control group has significantly higher RL level ( P〈0.05 ) while the Chinese medicine treatment group has significantly lower RL level ( P〈0.05 ). Compared with the untreated group, the control group has significantly higher RE level ( P〈0.05 ). Conclusion Tongbi Huaxian Decoction may improve Cydn and RL in rats with pulmonary fibrosis through reducing serum TNF-α levels, thereby delaying the process of pulmonary fibrosis.
  • 相关文献

参考文献9

  • 1American Thoracic Society/European Respiratory Society. American thoracic society/european respiratory society international multi- disciplinary consensus classification of the idiopathic interstitial pneumonias[J]. Am J RespirCrit Care Med, 2002, 165 (2): 277-304.
  • 2Sisson TH, Hanson KE ,Subbotina N ,et al. Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury inmice [ J]. Am J Physiol Lung Cell Mol Physiol,2002, 283 : 1023-1032.
  • 3FujimotoH, GabazzaEC, HatajiO, et al. Thrombin-activatable fi- brinolysis inhibitor and protein C inhibitor in interstitial lung disease [ J ]. Am J Res Critieal Care Meal,2003,167:1687-1694.
  • 4Clark JG. BLM-indueed Pulmonary fibrosis inhamster [ J]. J Clin Invest, 1983,72:20.
  • 5Thrall RS. Differential cellular during the development of bleomycin induced Pulmonary in the rat [ J ]. Am Rev Respir Dis, 1982, 126:488.
  • 6周刚,王继峰,牛建昭.姜黄素对肺纤维化大鼠肺功能的影响[J].中药新药与临床药理,2008,19(4):247-250. 被引量:6
  • 7汤军,徐志瑛,陈珺,付淑艳,宋嘉,孙洁.苏金抗纤饮对肺纤维化大鼠凝血-纤溶系统的影响[J].浙江中西医结合杂志,2007,17(3):138-139. 被引量:5
  • 8张伟,姜良铎,张晓梅,鲁香凤,吴建军,邓媛.肺纤方对博莱霉素致肺间质纤维化大鼠肺系数与肺组织病理的影响[J].北京中医药大学学报,2008,31(8):544-548. 被引量:9
  • 9Szapiel SV, Elson NA, Fulmer JD, et a[. Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse[ J]. Am Rev Respir Dis, 1979,120 : 893-899.

二级参考文献18

  • 1吴银根,张天嵩.络病理论指导肺纤维化中医证治探析[J].中医药学刊,2005,23(1):14-15. 被引量:60
  • 2张彦萍,王立芹.肺纤维化大鼠支气管肺泡灌洗液及血浆凝血、纤溶活性的变化[J].华中科技大学学报(医学版),2005,34(4):410-412. 被引量:4
  • 3易祥华.介绍特发性间质性肺炎的ATS/ERS分类及病理诊断[J].诊断病理学杂志,2005,12(6):401-404. 被引量:10
  • 4张川,袁高辉,韦凡平,王兴祥.肺原性心脏病心力衰竭患者的凝血纤溶系统活性变化[J].心脑血管病防治,2006,6(1):17-19. 被引量:7
  • 5SZAPIEL SV, ELSON NA, FULMER JD, et al. Bleomycin-induced interstitial pulmonary disease in the nude athymic mouse [J]. Am Rev Respir Dis, 1979, 120 (4): 893 - 901.
  • 6AMERICAN THORACIC SOCIETY, EUROPEAN RESPIRATORY SOCIETY. American Thoracic Society/ European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias [J]. Am J Respir Crit Care Med, 2002, 165 (2): 277 - 304.
  • 7Szapiel S V,Elson N A,Fulmer JD.Belomycin-induced interestitial pulmonary disease in the mude,athymic monse.Am Rev Respir Dis,1979,120:893.
  • 8Araujo CAC, Leon LL . Biological activities of Curcuma longa L[J]. Mere Inst Oswaldo Cruz, 2001, 96(5) : 723 - 728.
  • 9Motterlini R, Foresti R, Bassi R, et al, Curcumin, an antioxidant and anti- inflammatory agent, induces heme oxygenase^-1 and protects endothelial cells against oxidative stress[J]. Free Radic Biol Med, 2000, 28(8): 1303-1312.
  • 10Kang HC, Nan JX, Park PH, et al. Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro[J]. J Pharm Pharmaco, 2002, 54(1) : 119 - 126.

共引文献15

同被引文献21

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部